Reagent Proteins
Transcending the Limits of Protein Production
Pfenex Inc. is the leading protein expression company helping accelerate the development of new biotherapeutics and vaccines to address critical human health issues from infectious diseases to oncology.
Protein expression is difficult… the ability to successfully produce high titers of soluble, active protein in the first attempt results in significant opportunity cost avoidance and enables the rapid progression of therapeutic proteins and vaccine candidates from discovery through to commercialization. Pfenex Inc. produces high titers of proteins across a broad spectrum of functional types, from enzymes to antigens and engineered antibody fragments, rapidly and reliably.
Partners & Product Development
Pfenex Inc. partners with biopharmaceutical development organizations in the production of biopharmaceuticals. Utilizing the high throughput, combinatorial screening approach of Pfēnex Expression TechnologyTM, Pfenex has the unprecedented ability to produce proteins that cannot be otherwise expressed in any other system. Advantages include quality, stability, solubility, titer, rapid delivery as well as reduced production and development costs.
Great article about the Pfēnex Expression TechnologyTM and "Acheiving Optimal Expression of Fabs"